¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"fatty degeneration"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • angiolithic degeneration
    Ç÷°üµ¹º¯¼º, ¸Æ°ü°á¼®º¯¼º
  • axonal degeneration
    Ãà»èº¯¼º
  • age-related degeneration
    ³ªÀ̰ü·Ãº¯¼º, ³ë³â±âº¯¼º
  • alcoholic cerebellar degeneration
    ¾ËÄڿüҳúº¯¼º
  • ballooning degeneration
    dz¼±º¯¼º
  • cystic degeneration
    ³¶º¯¼º
  • degeneration
    º¯¼º, ÅðÇà
  • disciform macular degeneration
    ¿ø¹ÝȲ¹Ýº¯¼º
  • elastotic degeneration
    ź·Â¼¶À¯º¯¼º
  • fibrinoid degeneration
    ¼¶À¯¼Ò¸ð¾çº¯¼º, ÇǺ기¸ð¾çº¯¼º
  • hepatolenticular degeneration
    °£·»ÁîÇÙº¯¼º
  • hydropic degeneration
    ¼öÆ÷º¯¼º
  • lattice degeneration
    °ÝÀÚº¯¼º
  • liquefaction degeneration
    ¾×È­º¯¼º
  • malignant degeneration
    ¾Ç¼ºº¯¼º
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • angiolithic degeneration
    ¸Æ°ü°á¼®º¯¼º, Ç÷°üµ¹º¯¼º
  • axonal degeneration
    Ãà»èº¯¼º
  • ballooning degeneration
    dz¼±º¯¼º
  • cobblestone degeneration
    ÀÚ°¥¸ð¾çº¯¼º, Á¶¾àµ¹º¯¼º
  • cystic degeneration
    ³¶º¯¼º
  • degeneration
    º¯¼º, ÅðÇà
  • disciform macular degeneration
    ¿ø¹ÝȲ¹Ýº¯¼º
  • elastotic degeneration
    ź·Â¼¶À¯º¯¼º
  • endoglobular degeneration
    Ç÷±¸³»º¯¼º
  • equatorial degeneration
    Àûµµº¯¼º
  • hepatolenticular degeneration
    °£·»ÁîÇÙº¯¼º
  • hydropic degeneration
    ¼öÆ÷º¯¼º
  • lattice degeneration
    °ÝÀÚº¯¼º
  • liquefaction degeneration
    ¾×È­º¯¼º
  • malignant degeneration
    ¾Ç¼ºº¯¼º
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hepatocereberal degeneration
    °£³úº¯¼º
  • hepatolenticular degeneration
    °£·»ÁîÇÙº¯¼º
  • hepatolenticular degeneration
    °£·»ÁîÇÙº¯ ¼º.
  • hepatolenticular degeneration
    °£·»ÁîÇÙº¯ ¼º
  • hepatolenticular degeneration
    °£·»ÁîÇÙº¯¼º.
  • hereditary macular degeneration
    À¯Àü¼º Ȳ¹Ýº¯¼º(ë¶îîàõüÜÚèܨàõ).
  • hyaloideoretinal degeneration
    À¯¸®Ã¼¸Á¸·º¯¼º
  • pigmentary degeneration of retina
    ¸Á¸·»ö¼Òº¯¼º(Áõ)(ØÑدßäáÈܨàõ(ñø))
  • pigmentary retinal degeneration
    ¸Á¸·»ö¼Òº¯¼º
  • pigmentary retinal degeneration
    ¸Á¸·»ö¼Òº¯¼º(Áõ).(ØÑدßäáÈܨàõ(ñø))
  • posterolateral degeneration of spinal cord
    ô¼öÈÄÃø¼º º¯¼º(ô±âÐý­ö°àõܨ àõ).
  • posterolateral degeneration of spinal cord
    ô¼öÈÄÃø¼º º¯¼º(ô±âÐý­ö°àõ ܨàõ)
  • primary degeneration
    ÀÏÂ÷º¯¼º(ìéó­Ü¨àõ)
  • progressive lenticular degeneration
    ÁøÇ༺ ·»ÁîÇÙº¯¼º(Áõ)(òäú¼àõ¡­ú·Ü¨àõ(ñø))
  • pyramidal degeneration
    Ãßüº¯¼º(õÞô÷ܨàõ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • fatty exudate
    Áö¹æ»ïÃâ¹°, °æ¼º»ïÃâ¹°
  • fatty food intolerance
    Áö¹æ½ÄºÒ³»¼º(¡­ãÝÝÕÒ±àõ).
  • fatty ingrowth
    Áö¹æ ħÀ±(¡­öÙëÈ)
  • fatty liver
    Áö¹æ°£(ò·Û¸ÊÜ)
  • fatty liver
    Áö¹æ°£(ò·Û¸ÊÜ).
  • fatty liver
    Áö¹æ°£(ò·Û¸ÊÜ)
  • fatty oil
    Áö¹æÀ¯(̤ËÑËô).
  • fatty stool
    Áö¹æº¯(ò·Û¸øµ).
  • fatty streak
    Áö¹æ ¼±Á¶
  • free fatty acid
    À¯¸®Áö¹æ»ê.
  • free fatty acid.
    À¯¸®Áö¹æ»ê
  • non-esterified fatty acid
    ºñ¿¡½ºÅ׸£È­Áö¹æ»ê
  • nonesterified fatty acid
    ºñ¿¡½ºÅ׸£È­Áö¹æ»ê(Þª~ûùò·Û¸ß«).
  • normal fatty acid
    Ç¥ÁØÁö¹æ»ê(øöñÞò·Û¸ß«).
  • omega-3 fatty acid
    ¿À¸Þ°¡-3 Áö¹æ»ê(¡­ò·Û¸ß«)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • free fatty acids
    À¯¸® Áö¹æ»ê(ë´×îò·Û¸ß«)
  • iso fatty acid
    ¾ÆÀ̼ÒÁö¹æ»ê(ò·Û¸ß«)
  • long-chain fatty acid thiokinase
    ±ä»ç½½Áö¹æ»ê(ò·Û¸ß«) Ƽ¿ÀÄ«À̳×À̽º
  • medium-chain fatty acid thiokinase
    Áß(ñé)»ç½½ Áö¹æ»ê(ò·Û¸ß«) Ä¡¿ÀÄ«À̳×À̽º
  • monoenoic fatty acid
    ÀÏ(ìé)¿£ Áö¹æ»ê(ò·Û¸ß«)
  • odd-numbered fatty acid
    Ȧ¼ö Áö¹æ»ê(ò·Û¸ß«)
  • polyenoic fatty acid
    Æú¸®¿¡³ëÀÎ Áö¹æ»ê(ò·Û¸ß«)
  • polyunsaturated fatty acid
    ´ÙºÒÆ÷È­ Áö¹æ»ê(ÒýÝÕøéûúò·Û¸ß«)
  • saturated fatty acid
    Æ÷È­ Áö¹æ»ê(øéûùò·Û¸ß«)
  • unsaturated fatty acid
    ºÒÆ÷È­(ÝÕøéûú) Áö¹æ»ê(ò·Û¸ß«)
  • very long-chain fatty acids
    ¸Å¿ì ±ä »ç½½ Áö¹æ»ê(ò·Û¸ß«)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CMD Cerebro-Macular Degeneration
SCD   1) Sickle Cell Disease
  2) Subacute Combined Degeneration
AD accident dispensary; acetate dialysis; active disease; acute dermatomyositis; addict, addiction; ade...
AHCD acquired hepatocellular degeneration
AHD acquired hepatocerebral degeneration; acute heart disease; antihyaluronidase; antihypertensive drug;...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
NFD Neurofibrillary degeneration
PCD Paraneoplastic cerebellar degeneration
prcd Progressive rod-cone degeneration
PCD Purkinje Cell Degeneration
rds Retinal degeneration slow
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • subcutaneous fatty tissue
    ÇÇÇÏ Áö¹æ Á¶Á÷
  • total fatty acids
    ÃÑ Áö¹æ»ê
  • unesterified fatty acid
    ºñ¿¡½ºÅ׸£È­ Áö¹æ»ê
  • actinic degeneration
    ±¤¼± º¯¼º
  • amyloid degeneration
    ¾Æ¹Ð·ÎÀÌµå º¯¼º
  • axonal degeneration
    Ãà»è º¯¼º
  • ballooning degeneration
    °øÆ÷ º¯¼º, dz¼± º¯¼º, ±â±¸»ó º¯¼º
    Ç¥ÇÇ ¼¼Æ÷³» ºÎÁ¾À¸·Î ÀÎÇÏ¿© ¼¼Æ÷ÀÇ ½ÉÇÑ ÆØÃ¢À» ÀÏÀ¸Å² °Í.
  • calcareous corneal degeneration
    ¼®È¸ °¢¸· º¯¼º
  • calcific degeneration
    ¼®È¸È­ º¯¼º, ÅðÇ༺ ¼®È¸È­
    Ä¡¼ö½Ç º¸´Ù Ä¡¼ö °ü¿¡¼­ ÈçÇÏ´Ù. ¾àÇÑ µ¿Åë. ±¹¼Ò ´ë»ç Àå¾Ö³ª ¼Õ»ó ¼¼Æ÷ÀÇ ÃÊÀÚÈ­ µîÀÌ ¿øÀÎÀÌ´Ù.
  • cancerous degeneration
    ¾Ï º¯¼º
    ¾ÏÀ¸·Î º¯È¯ÇÏ´Â °Í. ¿¹¸¦ µé¸é ¾ç¼º Á¾¾ç¿¡¼­ ¾ÏÀ¸·Î º¯È¯ÇÏ´Â °Í.
  • cartilage degeneration
    ¿¬°ñ º¯¼º
    ¿¬°ñÀÌ °íµµÀÇ ÇüÀ¸·ÎºÎÅÍ ÀúµµÀÇ ÇüÀ¸·Î º¯È­.
  • cell,hydropic degeneration
    ¼öÆ÷¼º º¯¼º
  • cerebellar degeneration
    ¼Ò³ú º¯¼º
  • cerebromacular degeneration
    ³ú Ȳ¹Ý º¯¼º
  • cobblestone degeneration
    ÀÚ°¥ ¸ð¾ç º¯¼º, Æ÷¼®»ó º¯¼º
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
unesterified free fatty acid Free fatty acids which occur in plasma as a result of lipolysis in adipose tissue or when plasma triacylglycerols are taken into tissues.
(05 Mar 2000)
fatty Containing fat, or having the qualities of fat; greasy; gross; as, a fatty substance.
<medicine> Fatty acid, a tumour consisting of fatty or adipose tissue; lipoma.
Source: Websters Dictionary
(01 Mar 1998)
fatty acid <biochemistry> Any number of saturated aliphatic monocarboxylic acids. A metabolic byproduct from the breakdown of fats.
Chemically R COOH where R is an aliphatic moiety.
The common fatty acids of biological origin are linear chains with an even number of carbon atoms. Free fatty acids are present in living tissues at low concentrations. The esterified forms are important both as energy storage molecules and structural molecules.
See: triglycerides, phospholipids.
(15 Nov 1997)
fatty acid 2-chloroethyl ester synthase <enzyme> Catalyses the formation of 2-chloroethyl esters of long-chain fatty acids; localised in the microsomal fraction of rat liver
Registry number: EC 2.3.1.-
Synonym: facees, 2-chloroethyl ester synthase
(26 Jun 1999)
fatty-acid amide hydrolase <enzyme> Degrades neuromodulatory fatty-acid amides; genbank u72497
Registry number: EC 3.5.1.-
Synonym: oleamide hydrolase, faah protein, fatty acid amide hydrolase
(26 Jun 1999)
fatty acid binding protein A fatty acid-binding protein that participates in the intracellular movement of fatty acids.
Synonym: fatty acid binding protein.
(05 Mar 2000)
fatty acid binding proteins <biochemistry> Group of small cytosolic proteins that bind fatty acids or other organic solutes.
(18 Nov 1997)
fatty acid desaturases <enzyme> Enzymes that catalyze the conversion of saturated fatty acid CoA complexes to unsaturated fatty acid CoA complexes in the presence of any acceptor.
Registry number: EC 1.14.99.-
(12 Dec 1998)
fatty acid methyltransferase <enzyme> Catalyses the reaction of s-adenosylmethionine and a fatty acid to yield s-adenosylhomocysteine and a fatty acid methyl ester; calcium and calmodulin insensitive
Registry number: EC 2.1.1.15
(26 Jun 1999)
fatty acid oxidation cycle A series of reactions involving acyl-coenzyme A compounds, whereby these undergo beta oxidation and thioclastic cleavage, with the formation of acetyl-coenzyme A; the major pathway of fatty acid catabolism in living tissue.
(05 Mar 2000)
fatty acid reductase <enzyme> Catalyses reduction of fatty acids to aldehydes
Registry number: EC 1.2.1.-
(26 Jun 1999)
fatty acids Organic, monobasic acids derived from hydrocarbons by the equivalent of oxidation of a methyl group to an alcohol, aldehyde, and then acid. Fatty acids are saturated and unsaturated (fatty acids, unsaturated).
(12 Dec 1998)
fatty acids, essential Fatty acids that cannot be synthesised by the human body and must be obtained from dietary sources, e.g., linoleic acids and linolenic acids.
(12 Dec 1998)
fatty acids, monounsaturated Fatty acids which are unsaturated in only one position.
(12 Dec 1998)
fatty acids, nonesterified The fraction of plasma fatty acids that are not in the form of glycerol esters. They are also called free fatty acids, but this is a misnomer because they are transported complexed with albumin.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á